120 related articles for article (PubMed ID: 17876006)
1. Pyrrolidine dithiocarbamate and diethyldithiocarbamate are active against growing and nongrowing persister Mycobacterium tuberculosis.
Byrne ST; Gu P; Zhou J; Denkin SM; Chong C; Sullivan D; Liu JO; Zhang Y
Antimicrob Agents Chemother; 2007 Dec; 51(12):4495-7. PubMed ID: 17876006
[TBL] [Abstract][Full Text] [Related]
2. Synergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophages.
Mor N; Esfandiari A
Antimicrob Agents Chemother; 1997 Sep; 41(9):2035-6. PubMed ID: 9303411
[TBL] [Abstract][Full Text] [Related]
3. Effects of weak acids, UV and proton motive force inhibitors on pyrazinamide activity against Mycobacterium tuberculosis in vitro.
Wade MM; Zhang Y
J Antimicrob Chemother; 2006 Nov; 58(5):936-41. PubMed ID: 16950824
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 3-heteryl substituted pyrrolidine-2,5-diones via catalytic Michael reaction and evaluation of their inhibitory activity against InhA and Mycobacterium tuberculosis.
Matviiuk T; Mori G; Lherbet C; Rodriguez F; Pasca MR; Gorichko M; Guidetti B; Voitenko Z; Baltas M
Eur J Med Chem; 2014 Jan; 71():46-52. PubMed ID: 24269516
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium tuberculosis Is Selectively Killed by Rifampin and Rifapentine in Hypoxia at Neutral pH.
Iacobino A; Piccaro G; Giannoni F; Mustazzolu A; Fattorini L
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993848
[TBL] [Abstract][Full Text] [Related]
6. [Studies on the activity of the new antitubercular drugs: Pyrazinamide, rifomycin, 11.072 R. P].
Manowska W
Gruzlica; 1968 Apr; 36(4):387-8. PubMed ID: 4971135
[No Abstract] [Full Text] [Related]
7. Simple fibroblast-based assay to test the pyrazinamide susceptibility of Mycobacterium tuberculosis.
Takii T; Hamasaki S; Hirano K; Abe C; Onozaki K
Antimicrob Agents Chemother; 2005 Feb; 49(2):804-7. PubMed ID: 15673774
[TBL] [Abstract][Full Text] [Related]
8. Sterilising action of pyrazinamide in models of dormant and rifampicin-tolerant Mycobacterium tuberculosis.
Hu Y; Coates AR; Mitchison DA
Int J Tuberc Lung Dis; 2006 Mar; 10(3):317-22. PubMed ID: 16562713
[TBL] [Abstract][Full Text] [Related]
9. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
Dickinson JM; Aber VR; Mitchison DA
Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives.
Horita Y; Takii T; Kuroishi R; Chiba T; Ogawa K; Kremer L; Sato Y; Lee Y; Hasegawa T; Onozaki K
Bioorg Med Chem Lett; 2011 Feb; 21(3):899-903. PubMed ID: 21232949
[TBL] [Abstract][Full Text] [Related]
11. The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
Jindani A; Aber VR; Edwards EA; Mitchison DA
Am Rev Respir Dis; 1980 Jun; 121(6):939-49. PubMed ID: 6774638
[No Abstract] [Full Text] [Related]
12. The effects of rifampicin and fluoroquinolones on tubercle bacilli within human macrophages.
Duman N; Cevikbaş A; Johansson C
Int J Antimicrob Agents; 2004 Jan; 23(1):84-7. PubMed ID: 14732319
[TBL] [Abstract][Full Text] [Related]
13. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
[TBL] [Abstract][Full Text] [Related]
15. Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid.
Zhang Y; Wade MM; Scorpio A; Zhang H; Sun Z
J Antimicrob Chemother; 2003 Nov; 52(5):790-5. PubMed ID: 14563891
[TBL] [Abstract][Full Text] [Related]
16. Optimal dithiocarbamate structure for immunomodulator action.
Topping RJ; Jones MM
Med Hypotheses; 1988 Sep; 27(1):55-7. PubMed ID: 2849708
[TBL] [Abstract][Full Text] [Related]
17. [Culture and susceptibility testing of mycobacteria with VersaTREK].
Gravet A; Souillard N; Habermacher J; Moser A; Lohmann C; Schmitt F; Delarbre JM
Pathol Biol (Paris); 2011 Feb; 59(1):32-8. PubMed ID: 20850229
[TBL] [Abstract][Full Text] [Related]
18. Pyrazinamide susceptibility testing in all isolates of the Mycobacterium tuberculosis complex - a critical analysis.
Cunha J
Rev Port Pneumol; 2012; 18(4):188-9. PubMed ID: 22257727
[No Abstract] [Full Text] [Related]
19. Pyrazinamide resistance in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Abkhazia.
Pardini M; Varaine F; Hewison C; Iona E; Pataracchia M; Orefici G; Fattorini L
J Chemother; 2007 Feb; 19(1):106-7. PubMed ID: 17309862
[No Abstract] [Full Text] [Related]
20. [Determination of Mycobacterium tuberculosis' sensitivity to pyrazinamide on a BACTEC-960 bacteriological analyzer].
Irtuganova OA; Smirnova NS; Slogotskaia LV
Probl Tuberk Bolezn Legk; 2003; (7):40-2. PubMed ID: 12939878
[No Abstract] [Full Text] [Related]
[Next] [New Search]
